Visability during arthroscopic shoulder surgery: influence of epinephrine

Completed

• Conditions: impingement syndrome; shoulder tendon; 10043237

• Registration Number: NL-OMON38382
• Lead Sponsor: orthopaedie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 126

Inclusion Criteria

- Patients that are willing and able to participate in the study protocol
- Patients in need of arthroscopic shoulder surgery based on; a Bankart- or SLAP-lesion, a rotator cuff lesion, an impingement syndrome and or AC-joint pathology.

Exclusion Criteria

- patients with known cardiac diseases/ arrhithmia
- age under eighteen years
- language barrier
- mental disabilities
- Uncontrolled hypertension (* 180/110)
- Hypokalaemia
- Atopic asthma
- Constitutional allergy
- Sulphite allergy
- increased surgical risk( ASA >3)

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The difference in intra-operative clarity of the visual view between<br /><br>epinephrine and placebo subjects in: Mean VAS score; the main study parameter<br /><br>is a 2-point difference (20 %). </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Difference in mean blood pressure, potential cardiovasculair adverse reactions<br /><br>and serum epinephrine levels.</p><br>